David W Eisele
Overview
Explore the profile of David W Eisele including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
185
Citations
4146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
So R, Pham L, Eisele D, Motz K
Laryngoscope Investig Otolaryngol
. 2025 Jan;
10(1):e70068.
PMID: 39816922
Objectives: Hypoglossal nerve stimulation (HGNS) is a promising surgical option for patients with obstructive sleep apnea (OSA) who are intolerant of continuous positive airway pressure therapy (CPAP). Efficacy studies for...
2.
Garcia J, Yesantharao L, Frick K, Fakhry C, Koch W, Mydlarz W, et al.
Laryngoscope
. 2024 Jul;
134(12):4971-4978.
PMID: 38973626
Objective: Health care costs are disproportionately concentrated among a small number of patients. We sought to identify variables associated with high-cost patients and high hospital concentration of high-cost patients and...
3.
Alkhatib H, Maroun C, Guller M, Cooper D, Wu E, Eisele D, et al.
Otolaryngol Head Neck Surg
. 2023 Dec;
170(3):828-836.
PMID: 38123496
Objective: This study examines the association between patient-reported allergy history and immune checkpoint inhibition (ICI) response in patients with recurrent or metastatic head and neck squamous cell carcinoma (RMHNSCC). Study...
4.
Guller M, Cooper D, Alkhatib H, Suru A, Blancaflor A, Maroun C, et al.
Head Neck
. 2023 Sep;
45(11):2789-2797.
PMID: 37682116
Objectives: To explore the impact of pre-existing comorbidities on immunotherapy response, overall and progression-free survival, and immune-related adverse events (irAEs) of patients with advanced head and neck cancer (HNC) treated...
5.
Schwartz A, Jacobowitz O, Eisele D, Mickelson S, Miller M, Oliven A, et al.
JAMA Otolaryngol Head Neck Surg
. 2023 Apr;
149(6):512-520.
PMID: 37022679
Importance: Evidence is lacking from randomized clinical trials of hypoglossal nerve stimulation in obstructive sleep apnea (OSA). Objective: To evaluate the safety and effectiveness of targeted hypoglossal nerve stimulation (THN)...
6.
Lopez J, Reategui M, Rooper L, Koch W, Fakhry C, Mydlarz W, et al.
Laryngoscope
. 2022 Oct;
133(9):2160-2165.
PMID: 36197005
Introduction: A yield of ≥18 nodes from neck dissection has been shown to be associated with improved locoregional recurrence rates and survival. We sought to determine factors associated with lymph...
7.
Trakimas D, Perez-Heydrich C, Mandal R, Tan M, Gourin C, Fakhry C, et al.
Front Psychiatry
. 2022 Jul;
13:857083.
PMID: 35873237
Pain management is an important consideration for Head and Neck Cancer (HNC) patients as they are at an increased risk of developing chronic opioid use, which can negatively impact both...
8.
Saraswathula A, Austin J, Fakhry C, Eisele D, Kachalia A, Gourin C
J Clin Oncol
. 2022 Jun;
40(25):2996-2997.
PMID: 35671418
No abstract available.
9.
Saraswathula A, Austin J, Fakhry C, Vosler P, Mandal R, Koch W, et al.
Laryngoscope
. 2022 May;
133(4):834-840.
PMID: 35634691
Objective: To examine the relationship between surgeon volume and operative morbidity and mortality for laryngectomy. Data Sources: The Nationwide Inpatient Sample was used to identify 45,156 patients who underwent laryngectomy...
10.
Alkhatib H, Maroun C, Amin N, Zhu G, Guller M, Herberg M, et al.
JAMA Otolaryngol Head Neck Surg
. 2022 Apr;
148(6):540-546.
PMID: 35482301
Importance: Tumor histological factors that predict immunotherapy response in patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) are not well defined. Objective: To investigate the association...